Semi-Annual Statement Of Income

KYORIN Pharmaceutical Co., Ltd. - Filing #7717525

Concept 2018-04-01 to
2018-09-30
2018-04-01 to
2018-09-30
2018-04-01 to
2018-09-30
2018-04-01 to
2018-09-30
2018-04-01 to
2018-09-30
2017-04-01 to
2017-09-30
2017-04-01 to
2017-09-30
2017-04-01 to
2017-09-30
2017-04-01 to
2017-09-30
2017-04-01 to
2017-09-30
Semi-annual statement of income
Statement of income
Net sales
2,779,000,000 JPY
47,582,000,000 JPY
50,360,000,000 JPY
0 JPY
50,361,000,000 JPY
47,977,000,000 JPY
2,781,000,000 JPY
50,759,000,000 JPY
0 JPY
50,758,000,000 JPY
Cost of sales
23,758,000,000 JPY
23,128,000,000 JPY
Ordinary profit (loss)
3,183,000,000 JPY
1,693,000,000 JPY
Gross profit (loss)
26,602,000,000 JPY
27,630,000,000 JPY
Extraordinary income
2,000,000 JPY
627,000,000 JPY
Selling, general and administrative expenses
23,749,000,000 JPY
26,186,000,000 JPY
Extraordinary losses
73,000,000 JPY
420,000,000 JPY
Selling, general and administrative expenses
Profit (loss) before income taxes
3,111,000,000 JPY
1,900,000,000 JPY
Operating profit (loss)
26,000,000 JPY
2,673,000,000 JPY
2,852,000,000 JPY
152,000,000 JPY
2,700,000,000 JPY
1,222,000,000 JPY
75,000,000 JPY
1,297,000,000 JPY
145,000,000 JPY
1,443,000,000 JPY
Income taxes - current
611,000,000 JPY
487,000,000 JPY
Non-operating income
372,000,000 JPY
325,000,000 JPY
Income taxes - deferred
282,000,000 JPY
172,000,000 JPY
Non-operating income
Interest income
15,000,000 JPY
11,000,000 JPY
Dividend income
198,000,000 JPY
189,000,000 JPY
Income taxes
894,000,000 JPY
659,000,000 JPY
Non-operating expenses
42,000,000 JPY
75,000,000 JPY
Profit (loss)
2,217,000,000 JPY
1,240,000,000 JPY
Non-operating expenses
Interest expenses
12,000,000 JPY
13,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
2,000,000 JPY
50,000,000 JPY
Extraordinary losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.